bioMérieux
Meghan Lawson is a seasoned professional in market access and product strategy, currently serving as the Senior Market Access Product Strategy Manager at bioMérieux since March 2024. Prior to this role, Meghan held various positions at Cepheid from January 2010 to March 2024, including Senior Director of Market Access Strategy and Operations, Director of Reimbursement Strategy for Infectious Disease Point-of-Care Diagnostics, and Clinical Economic Research Associate. Meghan's academic credentials include a Master's degree in Health Law from Loyola University Chicago (2013-2015) and a Bachelor's degree in Biology and Economics from McDaniel College (2006-2009).
This person is not in any teams
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.